Apple Watch gets reformulated, non-patent-infringing blood oxygen monitoring

Feature had been removed from US Apple Watches after Apple lost a patent fight.

In early 2024, Apple removed a blood oxygen monitoring feature from its then-current Apple Watch Series 9 and Ultra 2 watches, following a ruling that the feature violated light-based pulse oximetry patents from a California-based company called Masimo. Removing the feature allowed Apple to circumvent an import ban and continue selling the Series 9 and Ultra 2 (and, later, the Series 10) in the US.

Today, Apple announced that it's restoring a version of the blood oxygen monitoring feature to affected Series 9, Series 10, and Ultra 2 watches. Apple says these updates were "enabled by a recent U.S. Customs ruling."

The feature has been redesigned, presumably to get around the Masimo patents that prompted the import ban in the first place. Apple says that sensor data from your watch will be sent to your iPhone for processing, and you can find the data in the Respiratory section of the Health app on your phone. The old version of the feature allowed results to be viewed directly on the Apple Watch, as shown in Apple's documentation.

Read full article

Comments

Thermoelektrik: Leistungsschub für Solarzellen durch breiteres Spektrum

Eine 15-fache Erhöhung der Effizienz macht die Thermoelektrik zu einer nutzbaren Energiequelle. Nicht nur die Kombination mit Photovoltaik ist denkbar. (Energiewende, Solarenergie)

Eine 15-fache Erhöhung der Effizienz macht die Thermoelektrik zu einer nutzbaren Energiequelle. Nicht nur die Kombination mit Photovoltaik ist denkbar. (Energiewende, Solarenergie)

Upcoming DeepSeek AI model failed to train using Huawei’s chips

Startup encountered persistent technical issues using Huawei Ascend chips.

Chinese artificial intelligence company DeepSeek delayed the release of its new model after failing to train it using Huawei’s chips, highlighting the limits of Beijing’s push to replace US technology.

DeepSeek was encouraged by authorities to adopt Huawei’s Ascend processor rather than use Nvidia’s systems after releasing its R1 model in January, according to three people familiar with the matter.

But the Chinese startup encountered persistent technical issues during its R2 training process using Ascend chips, prompting it to use Nvidia chips for training and Huawei’s for inference, said the people.

Read full article

Comments